Unusual Adverse Events After Treatment for Relapsed/Refractory Multiple Myeloma

By News Health
1 hour Ago

(MedPage Today) — The treatment of relapsed/refractory multiple myeloma dramatically changed in recent years with the emergence of therapies such as chimeric antigen receptor (CAR) T-cell products and antibody-drug conjugates. While these therapies…

Source link : https://www.medpagetoday.com/spotlight/multiple-myeloma/118326

Author :

Publish date : 2025-11-05 20:32:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Study Suggests Concerning Connections Between Seizures and Heart Disease

Helios-1: New quantum computer is on the path to unravelling superconductivity

ADHD Drug Recall; Postpartum Psychosis; Antibiotic for Schizophrenia Risk?

Digestive Tract Decontamination Fails to Cut Deaths in Intubated ICU Patients

New Hope for Hard-to-Treat Myasthenia Gravis

Pfizer COVID Vaccine Sales Tumble After Government Guidance on the Shots Narrows